Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
카바페넴 내성 그람음성균 감염의 항생제 치료Antimicrobial Therapy for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria
- Other Titles
- Antimicrobial Therapy for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria
- Issue Date
- 2018
- Publisher
- 대한내과학회
- Keywords
- Gram-negative bacteria; Carbapenem; Drug resistance; Treatment outcome; 그람음성균; 카바페넴; 약제내성; 치료 효과
- Citation
- 대한내과학회지, v.93, no.5, pp.439 - 446
- Indexed
- KCI
OTHER
- Journal Title
- 대한내과학회지
- Volume
- 93
- Number
- 5
- Start Page
- 439
- End Page
- 446
- ISSN
- 1738-9364
- Abstract
- Carbapenem-resistance emerging in Gram-negative pathogens, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, has become a major human health problem globally. The therapeutic options available for carbapenem- resistant pathogens are very limited. Antibiotics such as colistin, tigecycline, fosfomycin, and aminoglycosides are often the only ones that can be used to treat carbapenem-resistant pathogens. Carbapenem may still be an option in certain circumstances. The administration of combination therapy for carbapenem-resistant pathogens is controversial. This review presents the current knowledge of available antimicrobial therapeutic options for infections due to carbapenem-resistant pathogens in Korea.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.